Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Total Current Liabilities (2019 - 2025)

Vivos Therapeutics has reported Total Current Liabilities over the past 7 years, most recently at $18.1 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 263.12% to $18.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.1 million through Dec 2025, up 263.12% year-over-year, with the annual reading at $18.1 million for FY2025, 263.12% up from the prior year.
  • Total Current Liabilities was $18.1 million for Q4 2025 at Vivos Therapeutics, up from $7.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $18.1 million in Q4 2025 and troughed at $4.7 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $7.2 million (2023), against an average of $7.5 million.
  • The largest YoY upside for Total Current Liabilities was 263.12% in 2025 against a maximum downside of 41.75% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $7.5 million in 2021, then dropped by 9.27% to $6.8 million in 2022, then rose by 6.99% to $7.3 million in 2023, then crashed by 31.71% to $5.0 million in 2024, then surged by 263.12% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Total Current Liabilities are $18.1 million (Q4 2025), $7.4 million (Q3 2025), and $6.4 million (Q2 2025).